Efficacy and safety of combination treatment with tadalafil and mirabegron for persistent storage symptoms despite tadalafil treatment in patients with benign prostatic hyperplasia
| Autor: | T. Komi, Takehiro Sejima, K. Ono, Atsushi Takenaka, H. Matsuoka, N. Sakaridani, Masashi Honda, Y. Kimura, T. Isoyama, C. Takahashi |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry Urology Hyperplasia medicine.disease lcsh:Diseases of the genitourinary system. Urology lcsh:RC870-923 lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens lcsh:RC254-282 Tadalafil Combined treatment medicine In patient Mirabegron business medicine.drug |
| Zdroj: | European Urology Open Science, Vol 19, Iss, Pp e629-(2020) |
| ISSN: | 2666-1683 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|